[e-drug] Pharmacoeconomics - Evidence, Money & Selection

E-drug: Pharmacoeconomics - Evidence, Money & Selection
------------------------------------------------------------

*** FINAL ANNOUNCEMENT ***

*** APPLICATIONS CLOSE 14th January 2002 ***

Places are still available for the 3rd international short course on the
use of pharmaco-economics in drug selection, developed under the
auspices of WHO/EDM, to be held in India (Delhi and Jaipur) from
Feb 6 - Feb 16, 2002.

The aim of the program is to provide participants with an
understanding of the principles and techniques of pharmaco-
economics, and how these tools can be used in making decisions
about selecting and purchasing pharmaceuticals for use in health care
systems.

The course has been developed by an international consortium,
including departments of clinical pharmacology and public health at
the Universities of Newcastle (Australia), Sydney, and Birmingham
(UK), in collaboration with WHO/EDM.

The program in India will be provided by these groups and hosted
jointly by the Delhi Society for Promotion of Rational Use of Drugs,
the Rajasthan Society for Promotion of Rational Use of Drugs, the
Institute of Human Behaviour and Allied Sciences, the All India
Institute of Medical Sciences, and the National Institute of Health
and Family Welfare. The confirmed faculty include David Henry,
Suzanne Hill, Nick Freemantle, Glenn Salkeld and staff from WHO.

The course is problem-based, facilitated by international and
national experts. It provides participants with the opportunity to
work in small groups, learning about and using pharmacoeconomic
techniques to address common problems in selecting drugs for
national and sub-national formularies. Participants should therefore
be working in some aspect of the academic or public health sector,
and have some responsibility, either at managerial level or "hands
on" level, for selection of pharmaceuticals for essential drugs lists
or hospital formularies. Participants should also have a basic
understanding of the principles of assessing and evaluating data for
drug selection.

Fees: $US1600 [dual occupancy] $US1900 [single occupancy]
The fee covers tuition and all course materials, accommodation,
breakfast and lunch and travel between venues, and attendance at
the opening and closing dinners.

Participants must arrange their own sponsorship. The course fee
does not include travel costs, insurances or incidental expenses.

Language: English

Closing date: 7 JANUARY 2002.
The number of participants will be limited to 40.

Further information about the course can be obtained from:

Suzanne Hill
WHO Collaborating Centre for Training in Pharmacotherapy &
Rational Drug Use
University of Newcastle, Australia
e-mail hillsu@mail.newcastle.edu.au

--------------------------------------------
David Newby, B.Pharm. Grad Dip Epi(Pharmaco)
Research Academic
Discipline of Clinical Pharmacology
School of Population Health Sciences
Faculty of Medicine and Health Sciences
University of Newcastle
Mater Hospital
Edith St.
Waratah NSW 2298

Tel: +61 2 49211292
Fax: +61 2 49602088
Mobile: 0411126333

--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: owner-e-drug@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html